SEC Form 4 · accession 0001209191-15-056866
ZEVRA THERAPEUTICS, INC. · ZVRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
R. LaDuane Clifton
Officer — Chief Financial Officer
Period of report
Jun 25, 2015
Accepted (ET)
Jun 26, 2015 · 5:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434647
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $18.29 | Jun 25, 2015 | A | 45,000 | A | — | Jun 24, 2025 | Common Stock | 45,000 | 45,000 | D |
Explanation of responses
- F1Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the "Plan"). 25% of the total shares subject to the option vest in equal annual installments beginning on June 25, 2016 through June 25, 2019, provided, that in the event that the Company terminates the Reporting Person's employment without Cause or for Good Reason three (3) months prior to or within twelve (12) months following a Change in Control (as defined in the Plan), then the option shall become fully vested and immediately exercisable as of such date. The option expires ten years after the date of grant.